alexa Integrin α1β1 Overexpression Confers Pro-proliferative And Pro-migratory Advantage To Colorectal Cancer Tumours | 20040
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Tissue Science & Regenerative Medicine
September 24-26, 2014 Valencia Convention Centre, Spain

Salah Boudjadi and Jean-Fran?ois Beaulieu
Accepted Abstracts: J Tissue Sci Eng
DOI: 10.4172/2157-7552.S1.016
Abstract
B eing one of the leading causes of death from cancer in western countries, colorectal cancer (CRC) needs to be better understood to improve treatment. In the small intestine the α1 integrin subunit is present only in proliferating crypt cells while its exclusive partner β1 is constitutively expressed in all intestinal cells supporting a reported role for α1, via caveolin-1 and Shc, in the downstream activation of the Ras/ERK proliferative pathway. In mouse models, the α1β1 integrin supports breast cancer cell motility and, together with the Kras oncogenic factor, potentiates tumour growth. We postulated that integrin α1β1 is highly expressed in CRC and has a protumoral effect related to α1 subunit expression and regulation. Results: Immunofluorescence showed α1 only at the basolateral domain of proliferative crypt cells in the normal colon mucosa. Immunohistochemistry analysis performed on a tissue microarray containing 65 adenocarcinomas and their matched margins showed α1 to be highly expressed in 57% of tumours compared to margins, correlating with α1mRNA levels. Interestingly, α1 overexpression was present in the early stages of CRC. In the colorectal HT29 and SW480 tumour cell lines, α1 mRNA silencing resulted in reduced cell proliferation(52% and 54% respectively) and migration compared to the control. Our results show that α1β1is significantly over-expressed in CRC and is implicated in tumour progression.We are currently working on the regulation of the α1 sub unit, which could be a potential therapeutic target in the treatment of CRC.Supported by CIHR
Biography
Salah Boudjadi completed his residency in pathology at the University of Reims (France). His training was focused on the pathology of the gastrointestinal tract. Then he performed, at the University Paris 7, an internship in cytopathology of different organs including the liver and the pancreas. Thereafter, he followed a career in cancer research at the University of Sherbrooke, Canada. Currently he works on the regulation and function of various membrane proteins involved in colorectal cancer. He obtained grants from the Centre de recherchesur la biologie des ?pith?liums and from the Centre d?excellence of the University of Sherbrooke
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version